Global action on problematic usage of the internet: announcing a Lancet Psychiatry Commission.

Autor: Fineberg NA; Hertfordshire Partnership University NHS Foundation Trust, Hertfordshire, UK; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK; School of Clinical Medicine, University of Cambridge, Cambridge, UK., Demetrovics Z; College of Education, Psychology and Social Work, Flinders University, Adelaide, Australia; Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary; Centre of Excellence in Responsible Gaming, University of Gibraltar, Gibraltar., Potenza MN; Department of Psychiatry and Child Study Center, Yale School of Medicine, New Haven, CT, USA; Connecticut Mental Health Center, New Haven, CT, USA; Connecticut Council on Problem Gambling, Wethersfield, CT, USA; Department of Neuroscience and Wu Tsai Institute, Yale University, New Haven, CT, USA., Mestre-Bach G; Instituto de Investigación, Transferencia e Innovación, Universidad Internacional de La Rioja, La Rioja, Spain., Ekhtiari H; Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN, USA., Roman-Urrestarazu A; Mental Health Policy Economics Group, Department of Psychiatry, University of Cambridge, Cambridge, UK; Sección de Psiquiatría del Niño y del Adolescente, Pontificia Universidad Católica de Chile, Santiago, Chile; Bennett Institute for Public Policy, University of Cambridge, Cambridge, UK., Achab S; ReConnecte Specialized Centre, Addiction Division, University Hospitals of Geneva, Geneva, Switzerland; WHO Collaborating Center, Department of Psychiatry, Faculty of Medicine, Geneva University, Geneva, Switzerland; Advisory Board on Internet-related disorders, Swiss Federal Office of Public Health, Bern, Switzerland., Kattau T; International Drug Policy Academy, Pompidou Group, Strasbourg, France., Bowden-Jones H; National Centre for Behavioural Addictions, London, UK; Department of Psychiatry, University of Cambridge, Cambridge, UK; Faculty of Brain Sciences, University College London, London, UK., Thomas SA; Institute of Health and Wellbeing, Federation University of Australia, Ballarat, VIC, Australia., Babor TF; Department of Public Health Sciences, University of Connecticut School of Medicine, Farmington, CT, United States., Kidron B; 5Rights Foundation, London, UK., Stein DJ; SAMRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry & Neuroscience Institute, University of Cape Town, Cape Town 7925, South Africa. Electronic address: dan.stein@uct.ac.za.

Publikováno v: The lancet. Psychiatry [Lancet Psychiatry] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.

Neuroimaging Biomarkers in Addiction.

Autor: Ekhtiari H; Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA (Ekhtiari); Laureate Institute for Brain Research (LIBR), Tulsa, OK, USA (Ekhtiari, Paulus); School of Psychological Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia (Sangchooli); Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA (Carmichael); Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA (Oquendo, Childress); Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA (Moeller); Translational Medicine, Sage Therapeutics, Cambridge, MA, USA and McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, MA, USA (O'Donnell); Division of Depression and Anxiety, McLean Hospital, Belmont, MA, USA (Pizzaggali); National Institute on Drug Abuse, Bethesda, MD, USA (Ramey); Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA (Schacht); Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran (Zare-Bidoky); Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA (Brady)., Sangchooli A; Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA (Ekhtiari); Laureate Institute for Brain Research (LIBR), Tulsa, OK, USA (Ekhtiari, Paulus); School of Psychological Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia (Sangchooli); Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA (Carmichael); Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA (Oquendo, Childress); Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA (Moeller); Translational Medicine, Sage Therapeutics, Cambridge, MA, USA and McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, MA, USA (O'Donnell); Division of Depression and Anxiety, McLean Hospital, Belmont, MA, USA (Pizzaggali); National Institute on Drug Abuse, Bethesda, MD, USA (Ramey); Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA (Schacht); Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran (Zare-Bidoky); Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA (Brady)., Carmichael O; Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA (Ekhtiari); Laureate Institute for Brain Research (LIBR), Tulsa, OK, USA (Ekhtiari, Paulus); School of Psychological Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia (Sangchooli); Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA (Carmichael); Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA (Oquendo, Childress); Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA (Moeller); Translational Medicine, Sage Therapeutics, Cambridge, MA, USA and McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, MA, USA (O'Donnell); Division of Depression and Anxiety, McLean Hospital, Belmont, MA, USA (Pizzaggali); National Institute on Drug Abuse, Bethesda, MD, USA (Ramey); Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA (Schacht); Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran (Zare-Bidoky); Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA (Brady)., Moeller FG; Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA (Ekhtiari); Laureate Institute for Brain Research (LIBR), Tulsa, OK, USA (Ekhtiari, Paulus); School of Psychological Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia (Sangchooli); Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA (Carmichael); Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA (Oquendo, Childress); Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA (Moeller); Translational Medicine, Sage Therapeutics, Cambridge, MA, USA and McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, MA, USA (O'Donnell); Division of Depression and Anxiety, McLean Hospital, Belmont, MA, USA (Pizzaggali); National Institute on Drug Abuse, Bethesda, MD, USA (Ramey); Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA (Schacht); Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran (Zare-Bidoky); Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA (Brady)., O'Donnell P; Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA (Ekhtiari); Laureate Institute for Brain Research (LIBR), Tulsa, OK, USA (Ekhtiari, Paulus); School of Psychological Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia (Sangchooli); Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA (Carmichael); Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA (Oquendo, Childress); Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA (Moeller); Translational Medicine, Sage Therapeutics, Cambridge, MA, USA and McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, MA, USA (O'Donnell); Division of Depression and Anxiety, McLean Hospital, Belmont, MA, USA (Pizzaggali); National Institute on Drug Abuse, Bethesda, MD, USA (Ramey); Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA (Schacht); Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran (Zare-Bidoky); Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA (Brady)., Oquendo M; Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA (Ekhtiari); Laureate Institute for Brain Research (LIBR), Tulsa, OK, USA (Ekhtiari, Paulus); School of Psychological Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia (Sangchooli); Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA (Carmichael); Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA (Oquendo, Childress); Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA (Moeller); Translational Medicine, Sage Therapeutics, Cambridge, MA, USA and McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, MA, USA (O'Donnell); Division of Depression and Anxiety, McLean Hospital, Belmont, MA, USA (Pizzaggali); National Institute on Drug Abuse, Bethesda, MD, USA (Ramey); Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA (Schacht); Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran (Zare-Bidoky); Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA (Brady)., Paulus MP; Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA (Ekhtiari); Laureate Institute for Brain Research (LIBR), Tulsa, OK, USA (Ekhtiari, Paulus); School of Psychological Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia (Sangchooli); Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA (Carmichael); Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA (Oquendo, Childress); Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA (Moeller); Translational Medicine, Sage Therapeutics, Cambridge, MA, USA and McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, MA, USA (O'Donnell); Division of Depression and Anxiety, McLean Hospital, Belmont, MA, USA (Pizzaggali); National Institute on Drug Abuse, Bethesda, MD, USA (Ramey); Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA (Schacht); Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran (Zare-Bidoky); Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA (Brady)., Pizzagalli DA; Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA (Ekhtiari); Laureate Institute for Brain Research (LIBR), Tulsa, OK, USA (Ekhtiari, Paulus); School of Psychological Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia (Sangchooli); Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA (Carmichael); Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA (Oquendo, Childress); Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA (Moeller); Translational Medicine, Sage Therapeutics, Cambridge, MA, USA and McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, MA, USA (O'Donnell); Division of Depression and Anxiety, McLean Hospital, Belmont, MA, USA (Pizzaggali); National Institute on Drug Abuse, Bethesda, MD, USA (Ramey); Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA (Schacht); Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran (Zare-Bidoky); Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA (Brady)., Ramey T; Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA (Ekhtiari); Laureate Institute for Brain Research (LIBR), Tulsa, OK, USA (Ekhtiari, Paulus); School of Psychological Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia (Sangchooli); Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA (Carmichael); Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA (Oquendo, Childress); Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA (Moeller); Translational Medicine, Sage Therapeutics, Cambridge, MA, USA and McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, MA, USA (O'Donnell); Division of Depression and Anxiety, McLean Hospital, Belmont, MA, USA (Pizzaggali); National Institute on Drug Abuse, Bethesda, MD, USA (Ramey); Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA (Schacht); Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran (Zare-Bidoky); Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA (Brady)., Schacht J; Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA (Ekhtiari); Laureate Institute for Brain Research (LIBR), Tulsa, OK, USA (Ekhtiari, Paulus); School of Psychological Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia (Sangchooli); Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA (Carmichael); Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA (Oquendo, Childress); Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA (Moeller); Translational Medicine, Sage Therapeutics, Cambridge, MA, USA and McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, MA, USA (O'Donnell); Division of Depression and Anxiety, McLean Hospital, Belmont, MA, USA (Pizzaggali); National Institute on Drug Abuse, Bethesda, MD, USA (Ramey); Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA (Schacht); Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran (Zare-Bidoky); Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA (Brady)., Zare-Bidoky M; Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA (Ekhtiari); Laureate Institute for Brain Research (LIBR), Tulsa, OK, USA (Ekhtiari, Paulus); School of Psychological Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia (Sangchooli); Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA (Carmichael); Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA (Oquendo, Childress); Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA (Moeller); Translational Medicine, Sage Therapeutics, Cambridge, MA, USA and McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, MA, USA (O'Donnell); Division of Depression and Anxiety, McLean Hospital, Belmont, MA, USA (Pizzaggali); National Institute on Drug Abuse, Bethesda, MD, USA (Ramey); Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA (Schacht); Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran (Zare-Bidoky); Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA (Brady)., Childress AR; Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA (Ekhtiari); Laureate Institute for Brain Research (LIBR), Tulsa, OK, USA (Ekhtiari, Paulus); School of Psychological Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia (Sangchooli); Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA (Carmichael); Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA (Oquendo, Childress); Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA (Moeller); Translational Medicine, Sage Therapeutics, Cambridge, MA, USA and McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, MA, USA (O'Donnell); Division of Depression and Anxiety, McLean Hospital, Belmont, MA, USA (Pizzaggali); National Institute on Drug Abuse, Bethesda, MD, USA (Ramey); Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA (Schacht); Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran (Zare-Bidoky); Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA (Brady)., Brady K; Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA (Ekhtiari); Laureate Institute for Brain Research (LIBR), Tulsa, OK, USA (Ekhtiari, Paulus); School of Psychological Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia (Sangchooli); Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA (Carmichael); Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA (Oquendo, Childress); Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA (Moeller); Translational Medicine, Sage Therapeutics, Cambridge, MA, USA and McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, MA, USA (O'Donnell); Division of Depression and Anxiety, McLean Hospital, Belmont, MA, USA (Pizzaggali); National Institute on Drug Abuse, Bethesda, MD, USA (Ramey); Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA (Schacht); Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran (Zare-Bidoky); Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA (Brady).

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Sep 03. Date of Electronic Publication: 2024 Sep 03.

Closing the loop between brain and electrical stimulation: towards precision neuromodulation treatments.

Autor: Soleimani G; Department of Psychiatry & Behavioral Sciences, University of Minnesota, Minneapolis, MN, USA.; Department of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran., Nitsche MA; Department of Psychology and Neuroscience, Leibniz Research Center for Working Environment and Human Factors, Dortmund, Germany.; Bielefeld University, University Hospital OWL, Protestant Hospital of Bethel Foundation, University Clinic of Psychiatry and Psychotherapy, and University Clinic of Child and Adolescent Psychiatry and Psychotherapy, Bielefeld, Germany., Bergmann TO; Neuroimaging Center, Focus Program Translational Neuroscience, Johannes Gutenberg University Medical Center Mainz, Mainz, Germany.; Leibniz Institute for Resilience Research, Mainz, Germany., Towhidkhah F; Department of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran., Violante IR; School of Psychology, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK., Lorenz R; Department of Psychology, Stanford University, Stanford, CA, USA.; MRC CBU, University of Cambridge, Cambridge, UK.; Department of Neurophysics, MPI, Leipzig, Germany., Kuplicki R; Laureate Institute for Brain Research, Tulsa, OK, USA., Tsuchiyagaito A; Laureate Institute for Brain Research, Tulsa, OK, USA., Mulyana B; Laureate Institute for Brain Research, Tulsa, OK, USA.; School of Electrical and Computer Engineering, University of Oklahoma, Tulsa, OK, USA., Mayeli A; University of Pittsburgh Medical Center, Pittsburg, PA, USA., Ghobadi-Azbari P; Department of Biomedical Engineering, Shahed University, Tehran, Iran.; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran., Mosayebi-Samani M; Department of Psychology and Neuroscience, Leibniz Research Center for Working Environment and Human Factors, Dortmund, Germany., Zilverstand A; Department of Psychiatry & Behavioral Sciences, University of Minnesota, Minneapolis, MN, USA., Paulus MP; Laureate Institute for Brain Research, Tulsa, OK, USA., Bikson M; City University of New York, New York, NY, USA., Ekhtiari H; Department of Psychiatry & Behavioral Sciences, University of Minnesota, Minneapolis, MN, USA. hekhtiari@laureateinstitute.org.; Laureate Institute for Brain Research, Tulsa, OK, USA. hekhtiari@laureateinstitute.org.

Publikováno v: Translational psychiatry [Transl Psychiatry] 2023 Aug 14; Vol. 13 (1), pp. 279. Date of Electronic Publication: 2023 Aug 14.

Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity: A Systematic Review.

Autor: Sangchooli A; Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Australia., Zare-Bidoky M; Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis.; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran., Fathi Jouzdani A; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran., Schacht J; Department of Psychiatry, University of Colorado School of Medicine, Aurora., Bjork JM; Institute for Drug and Alcohol Studies, Department of Psychiatry, Virginia Commonwealth University, Richmond., Claus ED; Department of Biobehavioral Health, The Pennsylvania State University, University Park., Prisciandaro JJ; Addiction Sciences Division, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston., Wilson SJ; Department of Psychology, The Pennsylvania State University, State College., Wüstenberg T; Field of Focus IV, Core Facility for Neuroscience of Self-Regulation (CNSR), Heidelberg University, Heidelberg, Germany., Potvin S; Department of Psychiatry and Addiction, Université de Montréal, Montréal, Quebec, Canada., Ahmadi P; Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada., Bach P; Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Baldacchino A; School of Medicine, University of St Andrews, St Andrews, Scotland., Beck A; Faculty of Health, Health and Medical University, Potsdam, Germany.; Department of Psychiatry and Neurosciences, Charité Campus Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany., Brady KT; Addiction Sciences Division, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston., Brewer JA; Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, Rhode Island., Childress AR; Perelman School of Medicine, University of Pennsylvania, Philadelphia., Courtney KE; Department of Psychiatry, University of California, San Diego., Ebrahimi M; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran., Filbey FM; Center for BrainHealth, School of Behavioral and Brain Sciences, University of Texas at Dallas., Garavan H; Department of Psychiatry, University of Vermont, Burlington., Ghahremani DG; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles., Goldstein RZ; Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York., Goudriaan AE; Department of Psychiatry, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Amsterdam, the Netherlands., Grodin EN; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles., Hanlon CA; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.; BrainsWay Inc, Winston-Salem, North Carolina., Haugg A; Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Heilig M; Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden., Heinz A; Department of Psychiatry and Neurosciences, Charité Campus Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany., Holczer A; Department of Neurology, Albert Szent-Györgyi Health Centre, University of Szeged, Szeged, Hungary., Van Holst RJ; Amsterdam Institute for Addiction Research, Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Joseph JE; Department of Neuroscience, Medical University of South Carolina, Charleston., Juliano AC; Department of Psychiatry, University of Vermont, Burlington., Kaufman MJ; McLean Hospital, Harvard Medical School, Belmont, Massachusetts., Kiefer F; Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Khojasteh Zonoozi A; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran., Kuplicki RT; Laureate Institute for Brain Research, Tulsa, Oklahoma., Leyton M; Department of Psychiatry, McGill University, Montreal, Quebec, Canada., London ED; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles., Mackey S; Department of Psychiatry, University of Vermont, Burlington., McClernon FJ; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina., Mellick WH; Addiction Sciences Division, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston., Morley K; Specialty of Addiction Medicine, Faculty of Medicine and Health, Sydney Medical School, University of Sydney, Sydney, Australia., Noori HR; McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge., Oghabian MA; Neuroimaging and Analysis Group, Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran., Oliver JA; TSET Health Promotion Research Center, University of Oklahoma Health Sciences Center, Oklahoma City., Owens M; Department of Psychiatry, University of Vermont, Burlington., Paulus MP; Laureate Institute for Brain Research, Tulsa, Oklahoma., Perini I; Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden., Rafei P; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran., Ray LA; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles., Sinha R; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut., Smolka MN; Department of Psychiatry, Technische Universität Dresden, Dresden, Germany., Soleimani G; Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis., Spanagel R; Institute of Psychopharmacology, Central Institute of Mental Health, Mannheim, Germany., Steele VR; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut., Tapert SF; Department of Psychiatry, University of California, San Diego., Vollstädt-Klein S; Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Wetherill RR; Perelman School of Medicine, University of Pennsylvania, Philadelphia., Witkiewitz K; Department of Psychology, University of New Mexico, Albuquerque., Yuan K; School of Life Science and Technology, Xidian University, Xi'an, China., Zhang X; Department of Psychology, School of Humanities and Social Science, University of Science and Technology of China, Anhui, China., Verdejo-Garcia A; Turner Institute for Brain and Mental Health, Monash University, Clayton, Australia., Potenza MN; Department of Psychiatry, Technische Universität Dresden, Dresden, Germany., Janes AC; Cognitive and Pharmacological Neuroimaging Unit, National Institute on Drug Abuse, Baltimore, Maryland., Kober H; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut., Zilverstand A; Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis., Ekhtiari H; Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis.; Laureate Institute for Brain Research, Tulsa, Oklahoma.

Publikováno v: JAMA psychiatry [JAMA Psychiatry] 2024 Apr 01; Vol. 81 (4), pp. 414-425.

World addiction medicine reports: formation of the International Society of Addiction Medicine Global Expert Network (ISAM-GEN) and its global surveys.

Autor: Ekhtiari H; Department of Psychiatry, University of Minnesota, Minneapolis, MN, United States.; Laureate Institute for Brain Research, Tulsa, OK, United States., Khojasteh Zonoozi A; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.; Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Rafei P; Trinity College Institute of Neuroscience (TCIN), Trinity College Dublin, Dublin, Ireland., Abolghasemi FS; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.; Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Pemstein D; Political Science and Public Policy & Challey Institute, North Dakota State University, Fargo, ND, United States., Abdelgawad T; Faculty of Medicine, Cairo University, Cairo, Egypt., Achab S; Faculty of Medicine, Sociological and Psychological Research Unit, Department of Psychiatry, University of Geneva, Geneva, Switzerland., Ghafri HA; National Rehabilitation Center, Abu Dhabi, United Arab Emirates., Al'Absi M; Department of Psychiatry, University of Minnesota, Minneapolis, MN, United States., Bisch M; Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France., Conti AA; Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom., Ambekar A; National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India., Arunogiri S; Monash Addiction Research Centre, Eastern Health Clinical School, Melbourne, VIC, Australia., Bhad R; National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India., Bilici R; Faculty of Medicine, Department of Psychology, Istanbul Ticaret University, Istanbul, Türkiye., Brady K; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States., Bunt G; School of Medicine, New York University, New York City, NY, United States., Busse A; Prevention, Treatment and Rehabilitation Section, United Nations Office on Drugs and Crime (UNODC), Vienna, Austria., Butner JL; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States., Danesh A; Division of Prevention Science, University of California, San Francisco, San Francisco, CA, United States., El-Khoury J; Lebanese Psychiatric Society, Beirut, Lebanon., Omari FE; Faculty of Medicine, University Mohammed Vth of Rabat, Rabat, Morocco., Jokūbonis D; Republican Center for Addictive Disorders, Lithuanian University of Health Sciences, Kaunas, Lithuania., de Jong C; Behavioral Science Institute, Radboud University, Nijmegen, Netherlands., Dom G; Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium., Ebrahimi M; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran., Fathi Jouzdani A; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran., Ferri M; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal., Galea-Singer S; DigitAS Project, Population and Behavioural Science, School of Medicine, University of St Andrews, St Andrews, United Kingdom.; National Health Service (NHS) Fife Addiction Services, Cameron Hospital, Windygates, United Kingdom., Parker DG; School of Public Health, National University of Cordoba, Cordoba, Argentina., Higuchi S; National Hospital Organization Kurihama Medical and Addiction Center, Yokosuka, Japan., Kathiresan P; Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, India., Khelifa E; Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia., Kouimtsidis C; National Office for Addressing Drugs, Athens, Greece.; Surrey and Borders Partnership, National Health Service (NHS) Foundation Trust, Leatherhead, United Kingdom.; Department of Medicine, Imperial College London, London, United Kingdom., Krupitsky EM; Department of Addictions, Bekhterev National Medical Research Center for Psychiatry and Neurology, St. Petersburg, Russia., Long J; Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Maremmani I; Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy.; UniCamillus, International Medical University in Rome, Rome, Italy., McGovern G; Irish Chapter of International Society of Addiction Medicine (IRE-ISAM), Dublin, Ireland., Mohaddes Ardabili H; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.; Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Rahimi-Movaghar A; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran., Rataemane ST; Department of Psychiatry, University of Limpopo, Polokwane, South Africa., Sangchooli A; Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, VIC, Australia., Sibeko G; Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa., Vella AM; Foundation for Social Welfare Services (FSWS), Sedqa, Santa Venera, Malta., Vista SBD; Department of Psychiatry and Behavioral Medicine, College of Medicine and Philippines General Hospital, University of the Philippines Manila, Manila, Philippines., Zare-Bidoky M; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran., Zhao M; Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China., Javed A; Pakistan Psychiatric Research Centre, Fountain House, Lahore, Pakistan., Potenza MN; Department of Psychiatry and Child Center, Yale School of Medicine, New Haven, CT, United States.; Connecticut Mental Health Center, New Haven, CT, United States.; Connecticut Council on Problem Gambling, Wethersfield, CT, United States.; Wu Tsai Institute and Department of Neuroscience, Yale University, New Haven, CT, United States., Baldacchino AM; DigitAS Project, Population and Behavioural Science, School of Medicine, University of St Andrews, St Andrews, United Kingdom.

Publikováno v: Frontiers in psychiatry [Front Psychiatry] 2024 Mar 11; Vol. 15, pp. 1230318. Date of Electronic Publication: 2024 Mar 11 (Print Publication: 2024).